Authors

• Richard Andrew Newcomb (ORCID: https://orcid.org/0000-0002-8251-6961)
• Jonas S. Jutzi (ORCID: https://orcid.org/0000-0002-1977-153X)
• Yi‐Bin Chen (ORCID: https://orcid.org/0000-0002-9554-1058)
• Thomas R. Spitzer (ORCID: https://orcid.org/0000-0003-1384-5742)
• Zachariah DeFilipp (ORCID: https://orcid.org/0000-0002-7994-8974)
• Haesook T. Kim (ORCID: https://orcid.org/0000-0003-4889-6849)
• Sarah Wall (ORCID: https://orcid.org/0000-0002-8845-1046)
• Paul V. O’Donnell (ORCID: https://orcid.org/0000-0002-8521-6024)
• Matthew J. Frigault (ORCID: https://orcid.org/0000-0002-6774-5694)
• Gabriela Hobbs (ORCID: https://orcid.org/0000-0002-0199-9333)
• Areej El‐Jawahri (ORCID: https://orcid.org/0000-0002-3556-1495)
• Jooho Chung (ORCID: https://orcid.org/0000-0003-3625-0143)
• Roni Tamari (ORCID: https://orcid.org/0000-0002-2386-0850)
• Mark A. Schroeder (ORCID: https://orcid.org/0000-0003-4924-8990)
• Steven L. McAfee
• Richard Hao

Institutions

• Brigham and Women's Hospital (US)
• Memorial Sloan Kettering Cancer Center (US)
• Washington University in St. Louis (US)
• The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (US)
• Massachusetts General Hospital (US)
• Dana-Farber Cancer Institute (US)
• Dana-Farber/Harvard Cancer Center (US)

Publication Details

Journal

JCO oncology advances.

Published

2025-08-01

DOI

https://doi.org/10.1200/oa-25-00020

Citations

3

Primary Topic

Myeloproliferative Neoplasms: Diagnosis and Treatment

Type

article

Field-Weighted Citation Impact

4.88